MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
Europe - FRA:ILM1 - DE000A1MMCC8 - Common Stock
14.42 EUR
+0.08 (+0.56%)
Overall ILM1 gets a fundamental rating of 4 out of 10. We evaluated ILM1 against 28 industry peers in the Health Care Providers & Services industry. While ILM1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ILM1 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILM1 was profitable.
In the past year ILM1 had a positive cash flow from operations.
ILM1 had positive earnings in each of the past 5 years.
ILM1 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ILM1 has a Return On Assets (1.61%) which is in line with its industry peers.
ILM1 has a Return On Equity of 2.89%. This is in the lower half of the industry: ILM1 underperforms 60.71% of its industry peers.
With a Return On Invested Capital value of 3.03%, ILM1 perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
ILM1 had an Average Return On Invested Capital over the past 3 years of 3.26%. This is below the industry average of 5.66%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROIC | 3.03% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
ILM1 has a Profit Margin of 0.78%. This is in the lower half of the industry: ILM1 underperforms 60.71% of its industry peers.
In the last couple of years the Profit Margin of ILM1 has declined.
Looking at the Operating Margin, with a value of 1.96%, ILM1 is doing worse than 71.43% of the companies in the same industry.
In the last couple of years the Operating Margin of ILM1 has declined.
The Gross Margin of ILM1 (8.91%) is worse than 75.00% of its industry peers.
In the last couple of years the Gross Margin of ILM1 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
ILM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ILM1 has been increased compared to 1 year ago.
The number of shares outstanding for ILM1 has been increased compared to 5 years ago.
Compared to 1 year ago, ILM1 has a worse debt to assets ratio.
2.2 Solvency
ILM1 has an Altman-Z score of 3.07. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
ILM1's Altman-Z score of 3.07 is amongst the best of the industry. ILM1 outperforms 92.86% of its industry peers.
ILM1 has a debt to FCF ratio of 8.28. This is a slightly negative value and a sign of low solvency as ILM1 would need 8.28 years to pay back of all of its debts.
ILM1 has a better Debt to FCF ratio (8.28) than 64.29% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that ILM1 is not too dependend on debt financing.
ILM1 has a Debt to Equity ratio of 0.37. This is amongst the best in the industry. ILM1 outperforms 89.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Altman-Z | 3.07 |
ROIC/WACC0.46
WACC6.6%
2.3 Liquidity
ILM1 has a Current Ratio of 1.96. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.96, ILM1 belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
ILM1 has a Quick Ratio of 1.42. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
ILM1 has a Quick ratio of 1.42. This is amongst the best in the industry. ILM1 outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ILM1 have decreased strongly by -22.32% in the last year.
ILM1 shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.00% yearly.
Looking at the last year, ILM1 shows a small growth in Revenue. The Revenue has grown by 5.62% in the last year.
The Revenue has been growing by 29.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
3.2 Future
Based on estimates for the next years, ILM1 will show a very strong growth in Earnings Per Share. The EPS will grow by 21.77% on average per year.
The Revenue is expected to grow by 4.11% on average over the next years.
EPS Next Y16.6%
EPS Next 2Y23.98%
EPS Next 3Y21.77%
EPS Next 5YN/A
Revenue Next Year8.34%
Revenue Next 2Y6.27%
Revenue Next 3Y5.86%
Revenue Next 5Y4.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.44, the valuation of ILM1 can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as ILM1.
The average S&P500 Price/Earnings ratio is at 27.20. ILM1 is around the same levels.
ILM1 is valuated reasonably with a Price/Forward Earnings ratio of 9.28.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 92.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, ILM1 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.44 | ||
| Fwd PE | 9.28 |
4.2 Price Multiples
78.57% of the companies in the same industry are more expensive than ILM1, based on the Enterprise Value to EBITDA ratio.
ILM1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.75 | ||
| EV/EBITDA | 6.82 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ILM1's earnings are expected to grow with 21.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y23.98%
EPS Next 3Y21.77%
5. Dividend
5.1 Amount
No dividends for ILM1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (9/17/2025, 5:29:19 PM)
14.42
+0.08 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap367.85M
Analysts85.45
Price Target26.3 (82.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.34%
PT rev (3m)-6.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.04%
EPS NY rev (3m)7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.44 | ||
| Fwd PE | 9.28 | ||
| P/S | 0.19 | ||
| P/FCF | 13.75 | ||
| P/OCF | 10.87 | ||
| P/B | 0.71 | ||
| P/tB | 26.84 | ||
| EV/EBITDA | 6.82 |
EPS(TTM)0.59
EY4.09%
EPS(NY)1.55
Fwd EY10.78%
FCF(TTM)1.05
FCFY7.27%
OCF(TTM)1.33
OCFY9.2%
SpS74.93
BVpS20.26
TBVpS0.54
PEG (NY)1.47
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROCE | 4.99% | ||
| ROIC | 3.03% | ||
| ROICexc | 3.44% | ||
| ROICexgc | 14.41% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% | ||
| FCFM | 1.4% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score4
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | 19.94% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 2.86 | ||
| Cash Conversion | 46.37% | ||
| Profit Quality | 179.07% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.07 |
F-Score4
WACC6.6%
ROIC/WACC0.46
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
EPS Next Y16.6%
EPS Next 2Y23.98%
EPS Next 3Y21.77%
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
Revenue Next Year8.34%
Revenue Next 2Y6.27%
Revenue Next 3Y5.86%
Revenue Next 5Y4.11%
EBIT growth 1Y25.3%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year110.41%
EBIT Next 3Y33.73%
EBIT Next 5Y29.68%
FCF growth 1Y140.67%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y136.45%
OCF growth 3Y6.19%
OCF growth 5YN/A